Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2010
03/11/2010WO2010027875A2 Compounds that modulate intracellular calcium
03/11/2010WO2010027564A2 Amido anti-viral compounds, compositions, and methods of use
03/11/2010WO2010027051A1 Substituted acetophenone compound, process for producing same, and use of same
03/11/2010WO2010026365A1 N-myristoyl transferase inhibitors
03/11/2010WO2010026075A1 Pyridine derivatives as inhibitors of hiv-i reverse transcriptase
03/11/2010WO2010025998A1 Insecticidal compounds
03/11/2010WO2010025871A1 4-halogen alkyl-substituted diaminopyrimidines for use as fungicides
03/11/2010WO2010025856A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010WO2010025831A1 Heterocyclically substituted anilinopyrimidines as fungicides
03/11/2010WO2010025553A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010WO2010008734A3 Methods of Preparing Imidazole-Based Bicyclic Compounds
03/11/2010WO2010004228A3 Polycyclic molecules discriminating neutron and gamma radiation
03/11/2010WO2010002115A3 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
03/11/2010WO2009158431A3 Pyrimidine derivatives as kinase inhibitors
03/11/2010WO2008094909A3 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
03/11/2010US20100063275 Process for preparing 6-phenoxypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivatives
03/11/2010US20100063249 Proton-conducting compound and proton-conducting polymer
03/11/2010US20100063117 Novel oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient
03/11/2010US20100063115 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and 5-(1,3,4-thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes
03/11/2010US20100063108 Pyridin-4-yl derivatives as immunomodulating agents
03/11/2010US20100063106 Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
03/11/2010US20100063104 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063078 Spirocompounds useful as modulators for dopamine d3 receptors
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063063 Substituted Heteroaryls
03/11/2010US20100063055 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
03/11/2010US20100063050 Novel heteropyrrole analogs acting on cannabinoid receptors
03/11/2010US20100063049 2-carbocycloamino-4-imidazolylpyrimidines as agents for the inhbition of cell proliferation
03/11/2010US20100063045 Novel pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
03/11/2010US20100063043 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics
03/11/2010US20100063041 Novel phenylpropionic acid derivatives as peroxisome proliferator-activated gamma receptor modulators, method of the same, and pharmaceutical composition comprising the same
03/11/2010US20100063040 Sulfonamide Derivative Having PGD2 Receptor Antagonistic Activity
03/11/2010US20100063036 Substituted morpholine and thiomorpholine derivatives
03/11/2010US20100063033 administering (2,6-Dimethyl-4-morpholin-4-yl-phenyl)-carbamic acid butyl ester, for the treatment of bipolar disorders, seizure disorders, anxiety disorders, neuropathic pain and migraine pain disorders or neurodegenerative disorders
03/11/2010US20100063031 Kinase inhibitor compounds
03/11/2010US20100063027 Amine Derivative Having NPY Y5 Receptor Antagonistic Activity
03/11/2010US20100063024 Dihydropyrazolopyrimidinone Derivatives
03/11/2010US20100062972 Triazole compounds and uses related thereto
03/11/2010US20100061960 Amido Anti-Viral Compounds, Compositions, And Methods Of Use
03/11/2010CA2735842A1 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
03/11/2010CA2735794A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
03/11/2010CA2735775A1 6-substituted benzoxazines
03/11/2010CA2734500A1 Compounds that modulate intracellular calcium
03/11/2010CA2732217A1 Insecticidal compounds
03/10/2010EP2161266A1 Benzofuran derivatives as orexin receptor antagonists
03/10/2010EP2161259A1 4-Haloalkyl substituted Diaminopyrimidine
03/10/2010EP2160391A1 Nicotinamide derivatives as synthesis units for producing agrochemical substances, and method for the production thereof
03/10/2010EP2160384A1 Process for the preparation of valsartan
03/10/2010EP2160381A2 Spirocyclic quinazoline derivatives and their use as pde7 inhibitors
03/10/2010EP1896456B1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
03/10/2010EP1841737B1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
03/10/2010EP1786801B1 2-arylcarbamoyl-indoles as cytokine inhibitors
03/10/2010EP1751113B1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/10/2010CN101668756A [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
03/10/2010CN101665469A Heterocyclic compounds useful as Nurrl activators
03/10/2010CN100593541C Benzopyran derivatives substituted with a thioxobenzoxazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
03/09/2010US7674909 Tetrahydroquinoline derivatives and their use as FSH receptor modulators
03/09/2010US7674828 Urea antagonists of P2Y1receptor useful in the treatment of thrombotic conditions
03/09/2010US7674823 DNA-PK inhibitors
03/09/2010US7674806 Amidines and derivatives thereof and pharmaceutical compositions containing them
03/09/2010US7674796 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one
03/09/2010US7674788 7-amino-6-chloro-2-piperazin-1-yl-4-pyrrolidin-1-yl-pteridine; central nervous system, respiratory, gastrointestinal or inflammatory diseases; joints, skin or eyes diseases; cancer; phosphodiesterase 4 inhibitors
03/09/2010CA2537598C Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
03/09/2010CA2493313C Novel benzodioxoles
03/09/2010CA2421819C Isoquinolinone potassium channel inhibitors
03/09/2010CA2140598C Prolineamide derivatives
03/04/2010WO2010025295A2 Compounds that modulate intracellular calcium
03/04/2010WO2010024227A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent
03/04/2010WO2010023609A1 Oxazole, oxadiazole and thiazole derivatives as diacylglycerol acyltranferase inhibitors
03/04/2010WO2010023446A1 Novel potassium channel blockers
03/04/2010WO2010023445A1 Novel potassium channel blocker
03/04/2010WO2010023307A1 Novel urea and thiourea derivatives
03/04/2010WO2010022725A1 Pyridine derivatives as vegfr-2 receptor and protein tyrosine kinase inhibitors
03/04/2010WO2009140466A3 Linezolid co-crystals
03/04/2010WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity
03/04/2010US20100056779 Synthesis of methyl nonactate derivatives
03/04/2010US20100056758 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
03/04/2010US20100056588 Histone deacetylase inhibitors
03/04/2010US20100056582 Modulators of LXR
03/04/2010US20100056581 Substituted Piperidino Phenyloxazolidinones
03/04/2010US20100056580 Novel crystalline salt form of an antidiabetic compound
03/04/2010US20100056571 Novel pyrazole compounds as transforming growth factor (tgf) inhibitors
03/04/2010US20100056567 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
03/04/2010US20100056527 Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
03/04/2010US20100056526 3-(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H)-one; for hypertension, cardiac disease, arteriosclerosis, kidney disease, stroke, dyslipidemia, obesity, diabetes, nonalcoholic steatohepatitis, dementia and/or Alzheimer's diseas
03/04/2010US20100056525 5- and 6- substituted benzimidazole thiophene compounds
03/04/2010US20100056524 Compound
03/04/2010US20100056523 Inhibitors of akt activity
03/04/2010US20100056522 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitor effect as active ingredient
03/04/2010US20100056521 (aza)indole derivative and use thereof for medical purposes
03/04/2010US20100056518 Cycloalkylamine substituted isoquinolone derivatives
03/04/2010US20100056517 Arylsulfonamide compounds
03/04/2010US20100056516 1-hydroxy naphthyridine compounds as anti-hiv agents
03/04/2010US20100056515 Benzimidazole compounds
03/04/2010US20100056514 Thienopyrazoles
03/04/2010US20100056513 Stereospecifically substituted benzo[1,3]dioxolyl derivatives
03/04/2010US20100056512 Pyrimidine compounds
03/04/2010US20100056509 Heteroaryl sulfonamides and ccr2
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 647